+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: not found

      Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein Kinase pathway.

      The Journal of Clinical Endocrinology and Metabolism
      Animals, Antibodies, pharmacology, Benzoquinones, CHO Cells, Cell Division, physiology, Cell Line, Cell Movement, drug effects, Cricetinae, Enzyme Inhibitors, Flavonoids, Fluorescent Antibody Technique, Focal Adhesion Kinase 1, Focal Adhesion Protein-Tyrosine Kinases, Humans, Insulin-Like Growth Factor Binding Protein 1, antagonists & inhibitors, Lactams, Macrocyclic, Mitogen-Activated Protein Kinases, metabolism, Oligopeptides, Phosphorylation, Protein Structure, Tertiary, Protein-Tyrosine Kinases, Quinones, Receptors, Fibronectin, genetics, immunology, Rifabutin, analogs & derivatives, Signal Transduction, Time Factors, Tissue Distribution, Trophoblasts, cytology

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          A highly migratory subpopulation of the human placental trophoblast, known as the extravillous trophoblast (EVT), invades the uterus and its vasculature, to establish adequate exchange of key molecules between the maternal and fetal circulations. During their formation, EVT cells selectively acquire alpha 5 beta 1 integrin. We had shown that alpha 5 beta 1 is required for their migratory function, and that EVT cell migration is stimulated by insulin-like growth factor-binding protein (IGFBP)-1 produced by the uterine decidua. The present study examined whether this stimulation is dependent on binding of the Arg-Gly-Asp (RGD) domain of IGFBP-1 to an RGD binding site on the alpha 5 beta 1 integrin, followed by activation of focal adhesion kinase (FAK) and stimulation of the mitogen-activated protein kinase (MAPK) pathway. IGFBP-1 treatment increased migration of EVT cells, whereas an anti-alpha 5 beta 1 integrin antibody blocked migration regardless of IGFBP-1 treatment. Migration stimulation by IGFBP-1 was abrogated by pretreatment with a Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP), but not a Gly-Arg-Gly-Glu-Ser-Pro (GRGESP) hexapeptide, and by mutation of the RGD domain of IGFBP-1 to Trp-Gly-Asp (WGD). IGFBP-1 treatment caused a rapid localization of immunoreactive FAK to cellular lamellipodia, a rapid increase in phosphorylation of FAK and extracellular-signal regulated kinases 1 and 2. Preincubation of EVT cells with Herbimycin A, a tyrosine kinase inhibitor, abrogated IGFBP-1 effects; whereas an MAPK kinase inhibitor, PD 98059, reduced migration regardless of IGFBP-1 treatment. These results indicate that IGFBP-1 stimulation of EVT cell migration occurs by binding of its RGD domain to the alpha 5 beta 1 integrin, leading to activation of FAK and stimulation of MAPK pathway.

          Related collections

          Author and article information


          Comment on this article